116 related articles for article (PubMed ID: 2186417)
1. Psychopharmacological strategies in the search for cognition enhancers.
Sanger DJ; Joly D
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():70-4. PubMed ID: 2186417
[TBL] [Abstract][Full Text] [Related]
2. The development of behavioral tests to assess the effects of cognitive enhancers.
Olton DS; Wenk L
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():65-9. PubMed ID: 2186416
[TBL] [Abstract][Full Text] [Related]
3. Problems in the search for cognition enhancers.
Hollister LE
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():33-6. PubMed ID: 2186410
[TBL] [Abstract][Full Text] [Related]
4. Animal models of cognitive function.
Decker MW
Crit Rev Neurobiol; 1995; 9(4):321-43. PubMed ID: 8829849
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
7. Preclinical research into cognition enhancers.
Sarter M
Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388
[TBL] [Abstract][Full Text] [Related]
8. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
Korff S; Harvey BH
Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
[TBL] [Abstract][Full Text] [Related]
9. Behavioral models of memory and amnesia.
Slangen JL; Earley B; Jaffard R; Richelle M; Olton DS
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():81-3; discussion 84. PubMed ID: 2186419
[TBL] [Abstract][Full Text] [Related]
10. Biochemical strategies in the search for cognition enhancers.
Briley M
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():75-80. PubMed ID: 2186418
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic target for cognition enhancers: diagnosis and clinical phenomenology.
Allain H; Boyer P; Kossmann L; Lépine JP; Kanowski S
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():49-51. PubMed ID: 2186412
[TBL] [Abstract][Full Text] [Related]
12. Biochemical models for cognition enhancers.
Costall B; Barnes JM; Hamon M; Müller WE; Briley M
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():85-8; discussion 89. PubMed ID: 2186420
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
14. Early clinical testing of cognition enhancers: prediction of efficacy.
Hall ST; Puech A; Schaffler K; Wesnes K; Gamzu ER
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():57-8; discussion 59. PubMed ID: 2186414
[TBL] [Abstract][Full Text] [Related]
15. Animal cognition: defining the issues.
Sarter M
Neurosci Biobehav Rev; 2004 Nov; 28(7):645-50. PubMed ID: 15555674
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
Brousseau G; Rourke BP; Burke B
Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological models for the study of cognition enhancers.
Delacour J; Bassant MH; Onofrj M; Santucci V; Kleinlogel H
Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():90-3. PubMed ID: 2186421
[TBL] [Abstract][Full Text] [Related]
18. Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic.
Day M; Balci F; Wan HI; Fox GB; Rutkowski JL; Feuerstein G
Curr Opin Investig Drugs; 2008 Jul; 9(7):696-706. PubMed ID: 18600575
[TBL] [Abstract][Full Text] [Related]
19. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
[TBL] [Abstract][Full Text] [Related]
20. Behavioral abnormalities in Alzheimer's disease.
Robert PH; Médecin I
Ann Med Interne (Paris); 1998 Jun; 149(4):216-20. PubMed ID: 11490549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
